Emergent BioSolutions (EBS) Stock Price & Financial Analysis
Emergent BioSolutions Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Emergent BioSolutions
What is the current stock price for EBS?
As of the latest trading session, EBS stock trades at $8.23. The 52-week range is $4.02–$14.06, with a day range of $8.06–$8.36.
What is the P/E ratio for EBS?
Emergent BioSolutions's trailing P/E ratio is 9.0, meaning investors pay $9.0 for every $1 of annual earnings. Emergent BioSolutions operates in the Healthcare sector.
Does EBS pay dividends?
Emergent BioSolutions does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for EBS?
Based on 1 analyst, the consensus for EBS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of EBS?
Emergent BioSolutions's market capitalization is $466.6M, classifying it as a small-cap company. Emergent BioSolutions operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.